A-021311

N/A

Report date: 2024/12/19 17:16:12

Base Information

Drug NameA-021311
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsThrombosisAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesYung Shin Pharm Ind Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYung Shin Pharm Ind Co Ltd
Active IndicationsN/A
Inactive IndicationsThrombosisAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A